Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Sesame Care vs SkinnyRx

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #7Desk pick
Sesame Care

An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

Marked down on: A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk

vs
Dispatch #49
SkinnyRx

Both molecules by needle or by tablet, with the whole term ladder printed on the product page before any intake — and a headline rate that is the twelve-month rung, charged as one $2,388 payment on day one.

Marked down on: FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026; the letter is public in FDA's warning-letter database

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

Sesame Care takes this head-to-head with the higher Desk Score, 87/100 (B+) against 78/100 (C+) for SkinnyRx. SkinnyRx still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Sesame Care

87/100

B+

Overall

SkinnyRx

78/100

C+

Price transparency

84
64

State access

92
86

Molecule range

94
92

Onboarding speed

84
80

Support responsiveness

80
80

Licensing & trust

92
62

The spec sheet

FieldSesame CareSkinnyRx
SemaglutideFrom $149/mo (brand Wegovy pill)$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
TirzepatideBrand Zepbound (price varies)$399/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
CoverageNationwide marketplace47 states + DC (not Alabama, Louisiana or Mississippi)
Brand-nameYesCompounded only
Oral optionYesYes
Best forShoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.Readers who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299.
Desk Score87/100B+78/100C+

The verdict

Desk pick — Sesame Care

Sesame Care takes this head-to-head with the higher Desk Score, 87/100 (B+) against 78/100 (C+) for SkinnyRx. SkinnyRx still holds its ground where its strengths line up with yours.

Choose Sesame Care if…

Shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.

From $149/mo (brand Wegovy pill) sema · Brand Zepbound (price varies) tirz · Nationwide marketplace

Choose SkinnyRx if…

Readers who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299.

$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay) sema · $399/mo month-to-month (compounded; the advertised rate is a 12-month prepay) tirz · 47 states + DC (not Alabama, Louisiana or Mississippi)

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Sesame Care · SkinnyRx.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.